Pharmacological properties and clinical outcomes of the anti-cancer drug, cabozantinib (CABOMETYX<sup>®</sup>)Tsuyoshi Osaka, Takahito Hara, Naoya Yamaguchi|Folia Pharmacologica Japonica|2021Cited by 1